Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,PI3,Elafin,Inverse variance weighted,30,1.13 [1.08-1.18],7.22330545393636e-08,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,IL19,Interleukin-19,Inverse variance weighted,30,1.09 [1.06-1.13],1.00902611690065e-06,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,30,1.05 [1.02-1.07],9.20293598694016e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,30,1.05 [1.03-1.08],9.78449127711016e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,30,1.09 [1.04-1.14],0.000150076928408242,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,30,1.06 [1.03-1.09],0.000268521561777528,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,30,1.06 [1.02-1.09],0.000420811663118178,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,30,1.06 [1.03-1.1],0.000490350233690917,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,30,1.05 [1.02-1.08],0.000632529842064854,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,30,1.06 [1.03-1.1],0.000651593535559911,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,EFNA1,Ephrin-A1,Inverse variance weighted,30,1.06 [1.02-1.09],0.00124586897825173,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,30,1.07 [1.03-1.11],0.00170130884592454,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,30,1.06 [1.02-1.09],0.00178924859314105,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,30,1.06 [1.02-1.1],0.0027759888309226,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,EFNA4,Ephrin-A4,Inverse variance weighted,30,1.06 [1.02-1.1],0.00287112397035345,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,IL36G,Interleukin-36 gamma,Inverse variance weighted,30,1.05 [1.02-1.09],0.00287946839772825,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,30,1.05 [1.02-1.08],0.00292750675349477,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,GPR15L,Protein GPR15L,Inverse variance weighted,30,1.05 [1.01-1.08],0.00434799520807385,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,30,1.05 [1.02-1.09],0.00461042282730226,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,30,1.06 [1.02-1.1],0.00464244475970522,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,PGF,Placenta growth factor,Inverse variance weighted,30,1.05 [1.01-1.09],0.00581668347438457,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,30,1.05 [1.01-1.1],0.00658839724504781,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CDH3,Cadherin-3,Inverse variance weighted,30,1.04 [1.01-1.08],0.00709293158782903,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,DSC2,Desmocollin-2,Inverse variance weighted,30,1.05 [1.01-1.09],0.0109501436300672,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,RNASE6,Ribonuclease K6,Inverse variance weighted,30,1.04 [1.01-1.07],0.0125380582646137,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,30,1.05 [1.01-1.09],0.0132699739101256,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,SBSN,Suprabasin,Inverse variance weighted,30,1.04 [1.01-1.07],0.0142646760504994,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,30,1.05 [1.01-1.09],0.0146296211036256,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,30,1.05 [1.01-1.1],0.0152697549952403,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,30,1.04 [1.01-1.07],0.0161518846860187,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,LGALS4,Galectin-4,Inverse variance weighted,30,1.05 [1.01-1.09],0.0165087663744168,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,30,1.03 [1.01-1.06],0.0201696273599264,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,LGALS9,Galectin-9,Inverse variance weighted,30,1.08 [1.01-1.16],0.0204328509203036,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,EREG,Proepiregulin,Inverse variance weighted,30,1.03 [1-1.06],0.0228128876140991,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,30,1.05 [1.01-1.1],0.0233418296189732,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,30,1.04 [1.01-1.08],0.023383503991057,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,30,1.05 [1.01-1.09],0.0246232761574772,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,ADA2,Adenosine deaminase 2,Inverse variance weighted,30,1.04 [1-1.08],0.0246643359113627,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,30,1.05 [1.01-1.1],0.0284949292628267,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,30,1.04 [1-1.08],0.0311435581052332,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,30,1.05 [1-1.1],0.0396205081219733,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,KLK13,Kallikrein-13,Inverse variance weighted,30,1.03 [1-1.07],0.0452482153242294,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,30,1.04 [1-1.08],0.0462732836004945,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,IL17C,Interleukin-17C,Inverse variance weighted,30,1.05 [1-1.11],0.0483267485174866,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,30,1.03 [1-1.06],0.0647973477750343,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,30,1.03 [1-1.07],0.0838764359825813,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,IL17A,Interleukin-17A,Inverse variance weighted,30,1.03 [0.99-1.07],0.108403606862344,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,30,1.03 [0.99-1.06],0.114770733990912,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,30,1.04 [0.99-1.1],0.12165510302182,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,IL22,Interleukin-22,Inverse variance weighted,30,1.04 [0.99-1.1],0.126544407245566,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,30,1.02 [0.99-1.05],0.13847553153879,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,30,1.04 [0.99-1.1],0.139744807735128,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CCL22,C-C motif chemokine 22,Inverse variance weighted,30,1.03 [0.99-1.07],0.140336066574584,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,30,1.04 [0.99-1.09],0.141759715573762,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,30,1.02 [0.99-1.05],0.15513222521505,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,AREG,Amphiregulin,Inverse variance weighted,30,1.03 [0.99-1.06],0.15654934524982,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,30,1.03 [0.99-1.06],0.166734260335146,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,30,1.03 [0.99-1.07],0.169894337314911,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,30,1.03 [0.99-1.07],0.186988339307048,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,30,1.02 [0.99-1.06],0.19904690305423,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,ULBP2,UL16-binding protein 2,Inverse variance weighted,30,1.02 [0.98-1.06],0.258036324822892,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CD27,CD27 antigen,Inverse variance weighted,30,1.02 [0.98-1.06],0.284191017948221,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,DSG3,Desmoglein-3,Inverse variance weighted,30,1.01 [0.99-1.04],0.292263882145398,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,PYDC1,Pyrin domain-containing protein 1,Inverse variance weighted,30,1.01 [0.99-1.04],0.292620347062612,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,NECTIN4,Nectin-4,Inverse variance weighted,30,1.02 [0.98-1.06],0.30581238805155,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,KLK11,Kallikrein-11,Inverse variance weighted,30,1.02 [0.98-1.06],0.325619795998753,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,30,1.02 [0.98-1.06],0.337037384627205,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,30,1.02 [0.98-1.06],0.353413433416284,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Inverse variance weighted,30,1.02 [0.98-1.05],0.378651581540591,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,LAYN,Layilin,Inverse variance weighted,30,1.02 [0.97-1.06],0.45909301672282,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,30,1.01 [0.98-1.04],0.557827756640257,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,KLK8,Kallikrein-8,Inverse variance weighted,30,1.01 [0.98-1.04],0.563123193662496,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,KLK10,Kallikrein-10,Inverse variance weighted,30,1.01 [0.98-1.04],0.595172747947025,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,KLK6,Kallikrein-6,Inverse variance weighted,30,1.01 [0.98-1.04],0.639143911306253,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,CDSN,Corneodesmosin,Inverse variance weighted,30,1.01 [0.98-1.04],0.657124811180165,trans
